SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

MERIGHI, Stefania
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.157
AS - Asia 8.489
EU - Europa 5.697
SA - Sud America 1.383
AF - Africa 138
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 8
Totale 32.884
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.835
SG - Singapore 3.317
CN - Cina 2.667
DE - Germania 1.322
BR - Brasile 1.146
UA - Ucraina 1.000
IT - Italia 975
HK - Hong Kong 839
TR - Turchia 725
GB - Regno Unito 575
VN - Vietnam 426
SE - Svezia 367
FI - Finlandia 364
RU - Federazione Russa 335
PL - Polonia 242
FR - Francia 185
CA - Canada 163
MX - Messico 132
AR - Argentina 97
ID - Indonesia 91
IN - India 91
NL - Olanda 86
JP - Giappone 72
BD - Bangladesh 71
ZA - Sudafrica 67
ES - Italia 56
BE - Belgio 47
IQ - Iraq 43
LT - Lituania 43
EC - Ecuador 39
CO - Colombia 22
CL - Cile 20
CZ - Repubblica Ceca 20
VE - Venezuela 20
AE - Emirati Arabi Uniti 19
MA - Marocco 19
AT - Austria 18
PY - Paraguay 17
PK - Pakistan 15
KR - Corea 14
IL - Israele 13
UZ - Uzbekistan 12
DZ - Algeria 11
KE - Kenya 11
AU - Australia 10
SA - Arabia Saudita 10
EG - Egitto 9
PE - Perù 9
JO - Giordania 8
NP - Nepal 8
IR - Iran 7
TN - Tunisia 7
BO - Bolivia 6
EU - Europa 6
IE - Irlanda 6
UY - Uruguay 6
AL - Albania 5
BG - Bulgaria 5
HN - Honduras 5
MY - Malesia 5
TW - Taiwan 5
BA - Bosnia-Erzegovina 4
CH - Svizzera 4
GT - Guatemala 4
KZ - Kazakistan 4
LV - Lettonia 4
NO - Norvegia 4
OM - Oman 4
PT - Portogallo 4
RO - Romania 4
AM - Armenia 3
DO - Repubblica Dominicana 3
HU - Ungheria 3
JM - Giamaica 3
KG - Kirghizistan 3
MO - Macao, regione amministrativa speciale della Cina 3
NI - Nicaragua 3
RS - Serbia 3
SN - Senegal 3
AO - Angola 2
BH - Bahrain 2
CG - Congo 2
ET - Etiopia 2
GA - Gabon 2
GE - Georgia 2
GR - Grecia 2
HR - Croazia 2
IM - Isola di Man 2
LU - Lussemburgo 2
MD - Moldavia 2
MK - Macedonia 2
PH - Filippine 2
PS - Palestinian Territory 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CY - Cipro 1
Totale 32.866
Salva come PNG Salva come JPEG
Città #
Singapore 1.933
Woodbridge 1.755
Ashburn 1.602
Fairfield 1.554
Jacksonville 1.093
Chandler 1.077
Houston 1.050
Ann Arbor 878
Beijing 870
Hong Kong 833
Santa Clara 815
Seattle 659
Wilmington 641
Cambridge 532
Dallas 396
Izmir 365
Nanjing 335
Los Angeles 317
Ferrara 300
Princeton 255
Warsaw 223
Munich 219
Milan 210
Boardman 201
New York 171
Ho Chi Minh City 155
Shanghai 144
Dearborn 126
São Paulo 120
San Diego 115
Shenyang 111
Nanchang 105
Addison 90
Hefei 89
Hanoi 86
Tianjin 86
Falkenstein 85
London 83
Bremen 82
Turku 80
Mexico City 77
Helsinki 73
Jakarta 71
Buffalo 69
Changsha 64
Hebei 64
Frankfurt am Main 63
Tokyo 62
Montreal 61
Brooklyn 54
Chicago 53
Jinan 47
Jiaxing 46
Bologna 45
Brussels 45
Orem 43
San Mateo 43
Toronto 42
San Francisco 41
Falls Church 39
Moscow 39
Boston 38
Johannesburg 36
Kunming 36
Poplar 36
Mountain View 35
Stockholm 34
Zhengzhou 34
Norwalk 33
Phoenix 33
Rio de Janeiro 33
Denver 32
Atlanta 31
The Dalles 31
Manchester 30
Chennai 29
Council Bluffs 27
Guangzhou 27
Auburn Hills 26
Ningbo 26
Haiphong 25
Philadelphia 25
Redwood City 25
Brasília 24
Mumbai 24
Columbus 23
Belo Horizonte 22
Amsterdam 21
Ankara 20
Des Moines 20
Orange 19
Rome 19
Verona 19
Dhaka 18
Nuremberg 18
Biên Hòa 17
Porto Alegre 17
Charlotte 16
Hangzhou 16
Lanzhou 16
Totale 21.993
Salva come PNG Salva come JPEG
Nome #
Pharmacology of Adenosine Receptors: The State of the Art 295
A glance at adenosine receptors: Novel target for antitumor therapy 262
Medicinal Chemistry, Pharmacology, and Clinical Implications of TRPV1 Receptor Antagonists 256
Inhibition of A2A Adenosine Receptor Signaling in Cancer Cells Proliferation by the Novel Antagonist TP455 254
A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy 236
Positive allosteric modulation of A1 adenosine receptors as a novel and promising therapeutic strategy for anxiety 229
A1 and A3 adenosine receptors inhibit LPS-induced hypoxia-inducible factor-1 accumulation in murine astrocytes 227
Characterization of adenosine receptors in bovine chondrocytes and fibroblast-like synoviocytes exposed to low frequency low energy pulsed electromagnetic fields 218
The A3 adenosine receptor: history and perspectives 217
Adenosine receptors and human melanoma 216
Pulsed Electromagnetic Field Exposure Reduces Hypoxia and Inflammation Damage in Neuron-Like and Microglial Cells 214
A(2B) adenosine receptors stimulate IL-6 production in primary murine microglia through p38 MAPK kinase pathway 211
Effects of two-carbon bridge region methoxylation of benztropine: discovery of novel chiral ligands for the dopamine transporter 200
Cannabinoid CB2 receptor attenuates morphine-induced inflammatory responses in activated microglial cells 200
Adenosine receptor targeting in health and disease 199
The activation of μ-opioid receptor potentiates LPS-induced NF-kB promoting an inflammatory phenotype in microglia 197
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 196
Multiple sclerosis lymphocytes upregulate A(2A) adenosine receptors that are antiinflammatory when stimulated 196
Alteration of A3 adenosine receptors in human neutrophils and low frequency electromagnetic fields 195
[H-3]-MRE 2029-F20, a selective antagonist radioligand for the human A(2B) adenosine receptors 195
Role and function of A2A and A3 adenosine receptors in patients with ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis 195
Antioxidant and antiinflammatory effects of epilobium parviflorum, melilotus officinalis and cardiospermum halicacabum plant extracts in macrophage and microglial cells 193
Adenosine modulates vascular endothelial growth factor expression via hypoxiainducible factor-1 in human glioblastoma cells. 190
Adenosine as a Multi-Signalling Guardian Angel in Human Diseases: When, Where and How Does it Exert its Protective Effects? 190
A3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: a pharmacological and biochemical study 185
Receptor binding thermodynamics as a tool for linking drug efficacy and affinity 184
Water-Soluble Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines as Human A3 Adenosine Receptor Antagonists 184
Adenosine receptors and cancer 183
van't Hoff Based Thermodynamics 183
A3 adenosine receptor activation inhibits cell proliferation via phosphatidylinositol 3-kinase/Akt-dependent inhibition of the extracellular signal-regulated kinase 1/2 phosphorylation in A375 human melanoma cells 182
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells 181
[3H]-MRE 2029-F20, a novel selective antagonist radioligand, for the pharmacological and biochemical characterization of A2B receptors. 180
Adenosine modulates vascular endothelial growth factor expression via hypoxia-inducible factor-1 in human glioblastoma cells 179
Modulation of metalloproteinase-9 in U87MG glioblastoma cells by A3 adenosine receptors 179
HIF-1 neuroprotection through erythropoietin increase in hypoxia: a role for A1 adenosine receptors 178
Pathological overproduction: the bad side of adenosine 178
Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A(2B) adenosine receptor antagonists 177
[H-3]MRE 3008F20: A novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors 177
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 177
The Anti-Tumor Effect of A(3) Adenosine Receptors Is Potentiated by Pulsed Electromagnetic Fields in Cultured Neural Cancer Cells 176
Synthesis and pharmacology of 6-substituted benztropines: Discovery of novel dopamine uptake inhibitors possessing low binding affinity to the dopamine transporter 175
Expression of A3 adenosine receptors in human lymphocytes: up-regulation in T cell activation 172
A(2A) adenosine receptors are differentially modulated by pharmacological treatments in rheumatoid arthritis patients and their stimulation ameliorates adjuvant-induced arthritis in rats 172
Biological effects of novel 2-amino-3-naphthoylthiophenes as allosteric enhancers of the A1 adenosine receptors 172
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 171
Adenosine receptors in health and disease 171
Adenosine Receptors as a Biological Pathway for the Anti-Inflammatory and Beneficial Effects of Low Frequency Low Energy Pulsed Electromagnetic Fields 171
Agonists and antagonists: Molecular mechanisms and therapeutic applications 171
M3 muscarinic receptors in peripheral lung parenchima of patients with chronic obstructive pulmonary disease. 170
A3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: A pharmacological and biochemical study. 170
Pharmacological and biochemical characterization of adenosine receptors in the human malignant melanoma A375 cell line. 169
Binding thermodynamic characterization of human P2X1 and P2X3 purinergic receptors 168
Adenosine receptors in colon carcinoma tissues and colon tumoral cell lines: focus on the A3 adenosine receptors. 167
Binding thermodynamics at the human cannabinoid CB1 and CB2 receptors 166
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells. 166
A(2A) adenosine receptors in human peripheral blood cells 165
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells. 164
[3H]MRE2029F20 a new selective antagonist radioligand for the human A2B adenosine receptors. 164
Thermodynamic analysis in drug-receptor binding: the A3 adenosine receptor 164
Thermodynamics of A2B adenosine receptor binding discriminates agonistic from antagonistic behaviour 162
Adenosine and lymphocyte regulation 162
Biochemical and pharmacological role of A1adenosine receptors and their modulation as novel therapeutic strategy 161
New potent and selective human adenosine A3 receptor antagonists. 161
New pyrrolo[2,1-f]purine-2,4-dione and imidazo[2,1-f]purine-2,4-dione derivatives as potent and selective human A(3) adenosine receptor antagonists 159
A3 adenosine receptors in human neutrophils and promyelocitic HL60 cells: a pharmacological and biochemical study. 159
Pulsed electromagnetic field and relief of hypoxia-induced neuronal cell death: The signaling pathway 159
Pyrazolotriazolopyrimidine derivatives sensitize melanoma cells to the chemiotherapic drugs: taxol and vindesine. 158
Synthesis, molecular modeling and SAR study of novel pyrazolo[5,1-f][1,6]naphthyridines as CB2receptor antagonists/inverse agonists 158
The A3 adenosine receptor: An enigmatic player in cell biology 157
THERMODYNAMICS OF A2B ADENOSINE RECEPTOR BINDING DISCRIMINATES AGONISTIC FROM ANTAGONISTIC BEHAVIOUR 156
Hydrogen sulfide modulates the release of nitric oxide and VEGF in human keratinocytes. 156
Expression, pharmacological profile and functional coupling of A2B receptors in a recombinant system and in peripheral blood cells by using a novel selective antagonist radioligand, [3H]MRE2029F20. 156
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 155
[3H]-MRE 3008-F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A3 adenosine receptors. 155
Targeting A3 and A2A adenosine receptors in the fight against cancer 154
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 153
MODULATION OF THE AKT/RAS/RAF/MEK/ERK PATHWAY BY A3 ADENOSINE RECEPTOR 153
Design, synthesis, and biological evaluation of C-9- and C-2-substituted pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c] pyrimidines as new A(2A) and A(3) adenosine receptors antagonists 151
[3H]MRE3008-F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A3 adenosine receptors. 151
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 151
Pharmacological and biochemical characterization of A3 adenosine receptors in Jurkat T cells. 150
Pharmacological characterization of adenosine receptors in bovine chondrocytes. 149
New potent and selective human adenosine A3 receptor antagonists 149
L'ipossia inibisce l'apoptosi indotta da paclitaxel mediante fosforilazione di BAD dipendente dall'adenosina nelle cellule di glioblastoma. 148
Caffeine inhibits adenosine-induced accumulation of hypoxia-inducible factor-1α, vascular endothelial growth factor, and interleukin-8 expression in hypoxic human colon cancer cells 146
Dose and time effects of caffeine intake on human platelet adenosine A2A receptors: functional and biochemical aspects. 146
Synthesis and activity of 3-pyridylamine ligands at central nicotinic receptors 145
Adenosine modulates HIF-1α, VEGF, IL-8, and foam cell formation in a human model of hypoxic foam cells 145
Effect of low frequency electromagnetic fields on A2A and A3 adenosine receptors in human neutrophils 144
[3H]-MRE 2029-F20, A Novel Selective Antagonist Radiolig and, for the Pharmacological and Biochemical Characterization of A2B Receptors. 144
Hypoxia inhibits paclitaxel-induced apoptosis through adenosine-mediated phosphorylation of bad in glioblastoma cells 144
MODULATION OF MMP-9 IN U87MG GLIOBLASTOMA CELLS BY A3 ADENOSINE RECEPTORS 144
Recettori dell'adenosina in tessuti tumorali e in linee cellulari di colon:"focus" sul recettore A3. 143
Adenosine A2A receptors in human circulating blood elements 143
Signaling pathways involved in anti-inflammatory effects of Pulsed Electromagnetic Field in microglial cells 142
Adenosine in a human model of Hypoxic foam cells 141
Nociceptin receptor binding in mouse forebrain membranes: Thermodynamic characteristics and structure activity relationships 141
Binding and functional parameters of A2A adenosine receptors in essential hypertensive patients before and after pharmacological treatment 140
Cytotoxic drugs regulate VEGF and IL-8 expression in human melanoma cells by A2A and A3 adenosine receptors. 140
Dose and time effects of caffeine intake on human platelet adenosine A2A receptors: functional and biochemical aspects 139
Totale 17.442
Salva come PNG Salva come JPEG
Categoria #
all - tutte 150.618
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 6.088
Totale 156.706
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.830 0 0 0 0 0 325 118 343 64 454 369 157
2021/20222.157 45 228 152 75 84 97 81 104 76 183 322 710
2022/20232.535 245 223 91 337 424 325 140 203 291 24 143 89
2023/20241.272 113 168 44 27 131 139 53 93 32 54 65 353
2024/20255.622 128 192 419 289 701 522 246 315 741 638 786 645
2025/20268.159 1.635 571 1.351 1.978 2.329 295 0 0 0 0 0 0
Totale 33.214